%1

Notice of intent to list imazalil as known to the State to cause cancer under Proposition 65.

Extension of the  public comment period on the draft templates for tabulating epidemiological and animal data in documents prepared for the Developmental and Reproductive Toxicant Identification Committee (DART IC).

-

Candidates for listing via the Authoritative Bodies mechanism found not to meet the regulatory criteria for reproductive toxicity: Thiabendazole, thiabendazole hypophosphate salt, and imazalil.

The Developmental and Reproductive Toxicant Identification Committee (DART IC) of OEHHA’s Science Advisory Board met on November 21, 2013.  As a discussion item, the Committee identified several items of information that would be useful to the members as they review epidemiological data in the hazard identification materials prepared for the various chemicals brought before them.  Public commenst regarding this informatin were requested.

-

Comment Period on Imazalil, a chemical being considered for listing by the Authoritative Bodies Mechanism

-

Imazalil under consideration for possible listing via the Authoritative Bodies mechanism: Request for relevant information.

Request for information as to whether methyl isobutyl ketone meets the criteria for listing as a reproductive toxicant under the authoritative bodies listing mechanism.

-

Start of public comment period on a draft table for presenting epidemiological data. The Developmental and Reproductive Toxicant Identification Committee reviewed a draft table and decided to discuss this further after the public had an opportunity to comment on this table as well as a similar table for tabulating data from studies in laboratory animals.

Comment period on chemicals being considered for listing by the Authoritative Bodies mechanism: thiabendazole and its hypophosphite salt.

-

Request for relevant information on thiabendazole and its hypophosphite salt, two chemicals under consideration for possible listing via the Authoritative Bodies mechanism.